Addiction and Rehabilitation Therapy

2000–Present FDA approves buprenorphine for clinical use (2002). In 2002, the FDA approved buprenorphine, a medication-assisted treatment (MAT) for opioid addiction. Unlike methadone, which is dispensed within a structured clinic, specially qualified physicians can prescribe buprenorphine.26 The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 passed. This act required insurance companies and group health […]